Use of Relaxin to Suppress Atrial Fibrillation

Description

Disclosed herein are methods of using relaxin polypeptides and analogs, or nucleic acid molecules encoding such polypeptides to treat or inhibit atrial fibrillation.

IP Status

https://patents.google.com/patent/US20220289809A1

Quick Facts:
Reference Number
02780
Technology Type
Therapeutic Modality
Technology Subtype
Drug Delivery / Formulation
Therapeutic Areas
Cardiovascular
Therapeutic Indications
Atrial fibrillation
Tags
Drug Repurposing
Lead Inventor
David Schwartzman
All Tech Innovators
Charles F. McTiernanGuy SalamaDavid S. SchwartzmanSanjeev Govinddas Shroff PhD
Date Submitted
2012-05-27
Collections
Cardiometabolic